Announcement No. 1144 Pursuant to section 30 of the Danish Capital Markets Act it is hereby announced that BlackRock, Inc.

HIBISCUS phase 2 data evaluating the safety profile and efficacy of etavopivat in adult and adolescent patients with sickle ...

RELEASE 28 November 2024, Copenhagen, Denmark Reinforcing its global leadership for High Pressure Grinding Rolls (HPGR), FLSmidth has received another order for the delivery...Læs mere » ...

Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody ...

Soon after warning that Russia’s newly deployed ‘Oreshnik’ nuclear capable hypersonic missile is able to reach any European capital, at a top speed of Mach 10+ —which is significantly faster than a ...

Fra Swissquote Nvidia announced another very strong quarter after the bell. The company surpassed its own revenue forecast by ...

BlackRock’s share capital and voting rights in DSVHolding in DSV A/S previouslyHolding in DSV as of 22 November 2024Share capital and voting rights attached to ...

Uddrag fra RBC Ukraine News, Saxo, Kyiv Post, Bloomberg og Zerohedge: About a day after President Biden authorized Ukraine to use the long-range US-made MGM-140 Army Tactical Missile System to strike ...

The biggest risk for Goldman’s US, Europe & China GDP growth estimates is “a large across-the-board tariff by the US, which would likely hit growth hard globally.” Next, we take a closer look at the ...